Sandler Alan B. sold RVMD
September 16, 2026 · Form 4 insider transaction
Sandler Alan B. sold 5 shares of Revolution Medicines, Inc. at $194.96 per share, a transaction worth $974.79. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
5
Price
$194.96
Total value
$974.79
InsiderSandler Alan B.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 16, 2026
Filing dateSeptember 18, 2026
Shares owned after53,204
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on June 13, 2026 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units.; Includes 209 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2026.